| 2025-12-17 |
详情>>
内部人交易：
Robbins Andrew R等共交易18笔
|
| 2025-11-13 |
详情>>
股本变动：
变动后总股本15350.56万股
变动原因 ▼▲
- 原因：
- 1.Common Stock offered 9,677,420 shares by the company
2.The Equity Underwriters exercised option in full to purchase up to an additional 1,451,613 shares of Common Stock
|
| 2025-11-10 |
复牌提示：
2025-11-10 06:55:00 停牌，复牌日期 2025-11-10 07:20:00
|
| 2025-11-07 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-1.55美元,归母净利润-2.26亿美元,同比去年增长-20.49%
|
| 2025-08-05 |
详情>>
业绩披露：
2025年中报每股收益-1.05美元,归母净利润-1.46亿美元,同比去年增长-24.06%
|
| 2025-05-06 |
详情>>
业绩披露：
2025年一季报每股收益-0.52美元,归母净利润-7198.6万美元,同比去年增长-23.37%
|
| 2025-04-22 |
股东大会：
将于2025-06-04召开股东大会
会议内容 ▼▲
- 1.To elect the two Class I director nominees named in the Proxy Statement to serve until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To ratify the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2025;
3.To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers;
4.To approve an amendment of the Company’s Certificate of Incorporation to provide for officer exculpation;
5.To transact any other matters that may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2025-02-25 |
详情>>
业绩披露：
2022年年报每股收益-1.73美元,归母净利润-1.4亿美元,同比去年增长-94.04%
|
| 2025-02-25 |
详情>>
业绩披露：
2024年年报每股收益-1.94美元,归母净利润-2.56亿美元,同比去年增长-32.98%
|
| 2024-11-12 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-1.85美元,归母净利润-1.88亿美元,同比去年增长-36.14%
|
| 2024-08-06 |
详情>>
业绩披露：
2024年中报每股收益-1.21美元,归母净利润-1.17亿美元,同比去年增长-41.9%
|
| 2024-08-06 |
详情>>
业绩披露：
2023年中报每股收益-1.14美元,归母净利润-8266.3万美元,同比去年增长-26.09%
|
| 2024-05-07 |
详情>>
业绩披露：
2024年一季报每股收益-0.62美元,归母净利润-5834.8万美元,同比去年增长-51.21%
|
| 2024-04-23 |
股东大会：
将于2024-06-05召开股东大会
会议内容 ▼▲
- 1.To elect the two Class III director nominees named in the Proxy Statement to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To ratify the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024;
3.To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers;
4.To conduct an advisory vote to determine the frequency of future advisory votes on the compensation of the Company’s named executive officers;
5.To approve an amendment to the Company’s Certificate of Incorporation to increase the number of authorized shares of the Company’s common stock from 150,000,000 to 300,000,000;
6.To transact any other matters that may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2024-02-26 |
详情>>
业绩披露：
2023年年报每股收益-2.42美元,归母净利润-1.92亿美元,同比去年增长-37.2%
|
| 2023-11-07 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-1.79美元,归母净利润-1.38亿美元,同比去年增长-37.19%
|
| 2023-04-25 |
股东大会：
将于2023-06-07召开股东大会
会议内容 ▼▲
- 1.To elect the three Class II director nominees named in the Proxy Statement to serve until the 2026 Annual Meeting of Stockholders or until their successors are duly elected and qualified;
2.To approve an increase of 6,000,000 shares reserved for issuance pursuant to our Amended and Restated 2018 Stock Option and Incentive Plan;
3.To ratify the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023;
4.To transact any other matters that may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2022-04-26 |
股东大会：
将于2022-06-07召开股东大会
会议内容 ▼▲
- 1.To elect the two Class I director nominees named in the Proxy Statement to serve until the 2025 Annual Meeting of Stockholders or until their successors are duly elected and qualified;
2.To ratify the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022;
3.To transact any other matters that may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-30 |
股东大会：
将于2021-06-16召开股东大会
会议内容 ▼▲
- 1.To elect the two Class III director nominees named in the Proxy Statement to serve until the 2024 Annual Meeting of Stockholders and until their successors are duly elected and qualified (“Proposal 1”);
2.To approve an increase of 6,000,000 shares reserved for issuance pursuant to our 2018 Stock Option and Incentive Plan (“Proposal 2”);
3.To ratify the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2021 (“Proposal 3”);
4.To transact any other matters that may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2020-11-06 |
详情>>
拆分方案：
每4.0000合并分成1.0000股
|
| 2020-10-09 |
股东大会：
将于2020-11-06召开股东大会
会议内容 ▼▲
- 1.To approve, in accordance with Nasdaq Listing Rule 5635, the issuance of the Company’s common stock, par value $0.001 per share, referred to as “Common Stock” or “our common stock”, upon conversion of the Company’s Series A Non-Voting Convertible Preferred Stock, par value $0.001 per share, or Series A Preferred Stock, issued in a merger that closed on July 6, 2020 and a private placement offering that closed on July 9, 2020 (the “Conversion Proposal” or “Proposal No. 1”);
2.To approve an amendment to our Third Amended and Restated Certificate of Incorporation, or Certificate of Incorporation, to effect a reverse stock split of the Company’s Common Stock at a ratio of between and including 1:4 and 1:8 (the “Reverse Stock Split Proposal” or “Proposal No. 2”);
3.To approve the adjournment or postponement of the Special Meeting, if necessary, to continue to solicit votes for the Conversion Proposal and/or the Reverse Stock Split Proposal (the “Adjournment Proposal” or “Proposal No. 3”).
|
| 2020-04-29 |
股东大会：
将于2020-06-09召开股东大会
会议内容 ▼▲
- 1.To elect two class II director to our Board of Directors, to serve until the 2023 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal;
2.To approve the adoption of an amendment to the Company’s Third Amended and Restated Certificate of Incorporation, to effect a reverse stock split at a ratio of not less than one-for-five and not more than one-for-ten, such ratio and the implementation and timing of such reverse stock split to be determined in the discretion of our Board of Directors, provided that any fractional shares resulting from the reverse stock split shall be automatically rounded up to the next whole share;
3.To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020;
4.To transact any other business properly brought before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2020-02-18 |
股东大会：
将于2020-03-09召开股东大会
会议内容 ▼▲
- 1.To approve a stock option exchange program for certain eligible employees, including certain of our executive officers, to exchange certain outstanding stock options for stock options with a lower exercise price;
2.To transact such other business as may properly come before the Special Meeting and any adjournments or postponements of the Special Meeting.
|
| 2019-04-30 |
股东大会：
将于2019-06-18召开股东大会
会议内容 ▼▲
- 1.To elect one class I director to our board of directors, to serve until the 2022 annual meeting of stockholders and until her successor has been duly elected and qualified, or until her earlier death, resignation or removal;
2.To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019;
3.To transact any other business properly brought before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|